Japan DMF (PMDA)

As of 31 December 2020

Japan DMF (PMDA)
Year APIs No
Total 49
2020 Entacapone, Ceftriaxone Sodium Hydrate 2
2019 Atorvastatin Calcium Hydrate 1 form, Azilsartan (A Form) 2
2018 - 0
2017 Blonanserin, Cefotiam Hydrochloride (sterile), Montelukast Sodium 3
2016 Atomoxetine Hydrochloride, Clarithromycin (Refine), Duloxetine Hydrochloride, Esomeprazole Magnesium Trihydrate, Olmesartan Medoxomil 5
Before 2015 Atorvastatin Calcium Hydrate(1form), Atorvastatin Calcium Hydrate(αform), Cefixime Hydrate HQ, Cefoperazone Sodium(non-sterile), Cefotiam Hydrochloride(non-sterile), Cefroxadine Hydrate, Ceftriaxone Sodium Hydrate(sterile), Clarithromycin(oxime), Gimeracil, Mosapride Citrate Hydrate, Nateglinide (B form), Oteracil Potassium (KMnO4), Pitavastatin Calcium (A form), Pranlukast Hydrate, Simvastatin, Sulbactam Sodium (non-sterile), Sulbactam Sodium (sterile), Amlodipine Besilate, Aripiprazole (Form 1), Clarithromycin, Entecavir Hydrate, Losartan Potassium, Montelukast Sodium, Sarpogrelate Hydrochloride, Clopidogrel Sulfate, Irbesartan, Itopride Hydrochloride, Olanzapine, Rosuvastatin Calcuim, Telmisartan, Celecoxib, Cinacalcet Hydrochloride, Entacapone, Imidapril Hydrochloride, Luliconazole, Raloxifene Hydrochloride(Anhydrate), Raloxifene Hydrochloride Hydrate 37